Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention

Schneeweiss A, Lux MP, Janni W, Hartkopf AD, Nabieva N, Taran FA, Overkamp F, Kolberg HC, Hadji P, Tesch H, Woeckel A, Ettl J, Lueftner D, Wallwiener M, Mueller V, Beckmann M, Belleville E, Wallwiener D, Brucker SY, Schuetz F, Fasching P, Fehm TN (2018)

Publication Type: Journal article

Publication year: 2018

Journal

Geburtshilfe und Frauenheilkunde Georg Thieme Verlag

Book Volume: 78

Pages Range: 246-259

Journal Issue: 3

DOI: 10.1055/s-0044-101614

Abstract

The treatment of metastatic breast cancer has become more complicated due to increasing numbers of new therapies which need to be tested. Therapies are now being developed to treat special clinical or molecular subgroups. Even though intrinsic molecular subtypes play a major role, more and more new therapies for subgroups and histological subtypes are being developed, such as the use of PARP inhibitors to treat patients with BRCA mutations (breast and ovarian cancer). Supportive therapies are also evolving, allowing problems such as alopecia or nausea and vomiting to be treated more effectively. Treatment-related side effects have a direct impact on the prognosis of patients with metastatic breast cancer, and supportive therapy can improve compliance. Digital tools could be useful to establish better patient management systems. This overview provides an insight into recent trials and how the findings could affect routine treatment. Current aspects of breast cancer prevention are also presented.

Authors with CRIS profile

Naiba Nabieva Department of Obstetrics and Gynaecology Matthias Beckmann Lehrstuhl für Geburtshilfe und Frauenheilkunde Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

Universitätsklinikum Heidelberg DE Germany (DE) Universitätsklinikum Ulm DE Germany (DE) Eberhard Karls Universität Tübingen DE Germany (DE) OncoConsult DE Germany (DE) Marienhospital Bottrop DE Germany (DE) Krankenhaus Nordwest DE Germany (DE) Centrum für Hämatologie und Onkologie Bethanien DE Germany (DE) Universitätsklinikum Würzburg DE Germany (DE) Technische Universität München (TUM) DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Ruprecht-Karls-Universität Heidelberg DE Germany (DE) Universitätsklinikum Hamburg-Eppendorf (UKE) DE Germany (DE) ClinSol GmbH & Co.KG DE Germany (DE) Universitätsklinikum Düsseldorf DE Germany (DE)

How to cite

APA:

Schneeweiss, A., Lux, M.P., Janni, W., Hartkopf, A.D., Nabieva, N., Taran, F.-A.,... Fehm, T.N. (2018). Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention. Geburtshilfe und Frauenheilkunde, 78(3), 246-259. https://doi.org/10.1055/s-0044-101614

MLA:

Schneeweiss, Andreas, et al. "Update Breast Cancer 2018 (Part 2) - Advanced Breast Cancer, Quality of Life and Prevention." Geburtshilfe und Frauenheilkunde 78.3 (2018): 246-259.

BibTeX: Download